MedTrace Logo

Dosage of Intrathecal Hyperbaric Bupivacaine and the Incidence of Post Spinal Shivering.

NCT03356899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-04-30

No results posted yet for this study

Summary

Shivering is very common after spinal anaesthesia. Many studies have investigated the role of adding adjuvants to the local anaesthetics to decrease the incidence of post-spinal shivering. Non of the studies n the literature review have investigated the role of different dose of local anaesthetic alone in reducing the incidence of post-spinal shivering. In the present study the investigators aimed to compare the effect of different local anaesthetic dose in reducing post-spinal shivering.

Conditions

  • Cesarean Section; Shivering

Interventions

DRUG

Low dose bupivacaine 0.5% (8mg)

8 mg hyperbaric bupivacaine with added 25 µg fentanyl to form a total volume of 2.1 ml

DRUG

High dose bupivacaine 0.5% (10mg)

10 mg hyperbaric bupivacaine with added 25 µg fentanyl to form a total volume of 2.5

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • Ezzeldin Ibrahim, PhD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-30
Primary Completion
2018-08-29
Completion
2018-09-29

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03356899 on ClinicalTrials.gov